drugset

drugset / Trial / NCT03538704

Effect of Fertility-sparing Therapy of Early Endometrial Cancer

NCT03538704 ↗

Unknown 80 enrolled Peking University People's Hospital First Affiliated Hospital, Sun Yat-Sen University · collab Maternal and Child Health Hospital of Hubei Province · collab Peking University First Hospital · collab Peking University Third Hospital · collab Qilu Hospital of Shandong University · collab Tianjin Medical University General Hospital · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of Fertility-sparing Therapy of Early Endometrial Cancer.

Timeline

Start: 2015-01-01
Primary completion: 2020-03-31
Completion: 2020-12-31

Publications

Results Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012 Oct;207(4):266.e1-12. doi: 10.1016/j.ajog.2012.08.011. Epub 2012 Aug 10.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metformin	Small molecule	1 g	—
Subject	Metformin	Small molecule	1.5 g	—

Indications